Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nicotine patch and paroxetine for smoking cessation.

J D Killen1, S P Fortmann, A F Schatzberg

  • 1Stanford University School of Medicine, Palo Alto, California 94304-1885, USA. Killen@SCRDP.Stanford.EDU

Journal of Consulting and Clinical Psychology
|November 9, 2000
PubMed
Summary

This study found that combining nicotine patch therapy with paroxetine did not significantly increase smoking cessation rates overall. However, compliant participants showed higher abstinence rates with paroxetine, suggesting potential benefits requiring further research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drinking water plumbing systems are a hot spot for antimicrobial-resistant pathogens.

The Journal of hospital infection·2025
Same author

GDF15 linked to maternal risk of nausea and vomiting during pregnancy.

Nature·2023
Same author

Fetally-encoded GDF15 and maternal GDF15 sensitivity are major determinants of nausea and vomiting in human pregnancy.

bioRxiv : the preprint server for biology·2023
Same author

Resting and exercise haemodynamic characteristics of patients with advanced heart failure and preserved ejection fraction.

ESC heart failure·2021
Same author

Cross-sectional study of the prevalence, causes and management of hospital-onset diarrhoea.

The Journal of hospital infection·2019
Same author

Genome-wide meta-analysis identifies novel loci associated with free triiodothyronine and thyroid-stimulating hormone.

Journal of endocrinological investigation·2019

Area of Science:

  • Clinical Medicine
  • Pharmacology
  • Addiction Research

Background:

  • Smoking cessation remains a significant public health challenge.
  • Nicotine replacement therapy (NRT) is a common cessation aid.
  • Pharmacological adjuncts to NRT are being investigated to improve efficacy.

Purpose of the Study:

  • To evaluate the efficacy of adding paroxetine to transdermal nicotine system (TNS) for smoking cessation.
  • To assess the impact of different paroxetine dosages (20 mg and 40 mg) on abstinence rates.
  • To examine the effects on craving and depression symptoms.

Main Methods:

  • A double-blind, randomized controlled trial involving 224 smokers.
  • Participants were assigned to TNS + placebo, TNS + 20 mg paroxetine, or TNS + 40 mg paroxetine.

Related Experiment Videos

  • Abstinence rates were assessed at weeks 4, 10, and 26. A subgroup analysis of compliant participants was performed.

    • Main Results:

    • Overall abstinence rates did not differ significantly between groups.
    • Compliant participants showed statistically significant higher abstinence rates at Week 4 in both paroxetine groups compared to placebo.
    • Combined treatment showed benefits in reducing craving and depression symptoms.

    Conclusions:

    • While overall results were not statistically significant, paroxetine combined with TNS may offer benefits for compliant smokers.
    • Further research is needed to confirm the efficacy and safety profile of this combination therapy.
    • Paroxetine may represent a valuable adjunct to current smoking cessation strategies.